Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1628 | Thyroid (non-cancer) | ICEECE2012

Association between preoperative value of TSH and pathological findings in nodular thyroid disease

Paja M. , EtxeberrIa E. , Iglesias N. , Gutierrez T. , Ugalde A. , Oleaga A. , Arosa V. , Elorza R.

Higher serum TSH has been recently postulated as a predictor of thyroid malignancy in nodular thyroid disease. In addition, some reports have demonstrated its association with more advanced stages of differentiated thyroid cancer (DTC).Material and methods: We collected retrospectively preoperative serum TSH from patients who underwent total thyroidectomy in the period 2005–2011 in a single tertiary center. We recorded demographic data, nodule numbe...

ea0029p1806 | Thyroid cancer | ICEECE2012

Utility of repeated recombinant human TSH (rhTSH)-stimulated tiroglobulin (Tg) test in patients with differentiated thyroid carcinoma (DTC) without evidence of disease at their initial rh-TSH-stimulation test

Oleaga A. , Goni F. , Paja M. , Izuzquiza A. , Moreno C. , Arosa V. , Iglesias N. , Espiga J.

Current guidelines recommend measurement of rhTSH-stimulated Tg, with neck ultrasound 6–12 months after the initial therapy for DTC (Total thyroidectomy plus 100 mCiI131 ablation of the thyroid bed). Uncertainty persists regarding whether the subsequent follow up should be based on measurement of basal serum Tg or whether rhTSH-stimulated Tg should be performed and at what frequency. The aim of our study was to evaluate the utility of repeated rhTSH-stimulated Tg.<p c...

ea0029p449 | Clinical case reports - Thyroid/Others | ICEECE2012

Ampullary NET presenting as Virchow’s node

Paja M. , Arosa V. , Lizarraga A. , Ugarte E. , Atin del Campo V. , Arbide del Rio N. , Trevino B. Barrios , Iglesias N.

Troisier’s sign names a visible left cervical adenopathy (Virchow’s node) as the first sign of a pancreatic tumor, mainly adenocarcinomas, by dissemination through the thoracic duct. Neuroendocrine tumors (NET) of the ampulla of Vater are extremely rare, no more than 2% of ampullary malignancies, and account for <0.3% of all gastrointestinal NETs.A 59–year old woman presented with an enlarging painless left cervical node. Ultrasonograp...

ea0070aep457 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Real-life clinical experience with GLP1 analogs and SGLT2 inhibitors in the treatment of diabetes type 2 and obesity

Pérez-Rodríguez José , Calderón-Vicente Dulce , González-López Javier , Martín-Iglesias David , Alramadan Mubarak

Objectives: SGLT2 inhibitors and GLP1 analogs are the treatment of choice after metformin in patients with type 2 diabetes (DM2) and overweight-obesity (OB). The aim of this study is to analyze the effectiveness and safety of these treatments alone or in combination.Methodology: This is a retrospective observational study in the usual clinical practice. We analyzed the effects of SGLT2 inhibitors and GLP1 analogs treatments in patients with DM2 and OB wh...

ea0081ep1153 | Thyroid | ECE2022

Role of plasmapheresis in the management of severe amiodarone-induced hyperthyroidism refractory to conventional medical treatment

Garcia Izquierdo Belen , Angulo Macarena Contreras , Grao Laura Armengod , Garcia Gomez Carlos , Garcia Garcia Alvaro , Maroto Azucena Losa , Cabrera Jose Luis Bueno , Serrano Miguel Juan Garcia- Oria , Donoso Encarnacio n , Iglesias Pedro

Introduction: Amiodarone is an antiarrhythmic drug whose high iodine content may influence thyroid function. The first line treatment of amiodarone-induced hyperthyroidism (AIH) is mainly medical. Plasmapheresis has been used in cases of antithyroid intolerance or refractory hyperthyroidism, although clinical experience is poor.Clinical case: We present a case of a patient with structural heart disease and severe AIH refractory to medical treatment who r...